Philips Ultrasound, Inc.

Philips Ultrasound, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 1, 2020 and the most recent on May 1, 2020 (EPIQ Diagnostic Ultrasound System Series, Affiniti Diagnostic Ultrasound System Series, CX50 Diagnostic Ultrasound System, Sparq Diagnostic Ultrasound System, Lumify Diagnostic Ultrasound System). Its most common review panel is Radiology (1 device).